Study finds a steep decline in quality and safety measures, such as fall and infection hazards, after buyouts.

Sees major progress in science since 1918 Spanish flu outbreak, but says complications of politics have plagued every epidemic since.

Early stage test shows promise, but cardiologist notes more study needed into longer-term, unintended effects.

Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.

“The Uses of Haiti: Paul Farmer and the Origins of the Global Health Equity Movement” honored the late Harvard Med professor and co-founder of Partners In Health.

Experts at Massachusetts General Hospital and Harvard Medical School traced a baffling smooth-muscle disorder to a tiny regulatory RNA, solving a medical mystery that had plagued a teen since birth.

An emotion many avoid and view as an illness may actually help us thrive, psychologist David Rosmarin says.

Drug regulation expert explains how the problem was discovered, next steps for FDA, and the questions it raises about other products, supplements.